Arkas Pharma Profile
Key Indicators
- Authorised Capital ₹ 5.00 M
as on 13-12-2024
- Paid Up Capital ₹ 4.00 M
as on 13-12-2024
- Company Age 11 Year, 12 Days
- Last Filing with ROC 31 Mar 2023
- Revenue 41.81%
(FY 2020)
- Profit 19.60%
(FY 2020)
- Ebitda 31.48%
(FY 2020)
- Net Worth 31.88%
(FY 2020)
- Total Assets 33.43%
(FY 2020)
About Arkas Pharma
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 5.00 M and a paid-up capital of Rs 4.00 M, as per Ministry of Corporate Affairs (MCA) records.
Anil Gorantla, Raja Shekar, and Swapna Gorantla serve as directors at the Company.
- CIN/LLPIN
U24232TG2013PTC091634
- Company No.
091634
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
12 Dec 2013
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Arkas Pharma?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Anil Gorantla  | Director | 15-Nov-2014 | Current |
| Raja Shekar | Director | 11-Jun-2020 | Current |
| Swapna Gorantla | Director | 12-Dec-2013 | Current |
Financial Performance of Arkas Pharma.
Arkas Pharma Private Limited, for the financial year ended 2020, experienced significant growth in revenue, with a 41.81% increase. The company also saw a substantial improvement in profitability, with a 19.6% increase in profit. The company's net worth Soared by an impressive increase of 31.88%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Arkas Pharma?
In 2020, Arkas Pharma had a promoter holding of 36.25% and a public holding of 63.75%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Arkas Pharma?
Unlock and access historical data on people associated with Arkas Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Arkas Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Arkas Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
